tirzepatide heart UC Irvine researchers project cardiac benefits from weight-loss medication Tirzepatide Reduces Heart Failure Risk,

In particular, a decline in collagen autophagy (collagenophagy) structurally blocks ECM turnover and acts as a decisive factor in maintaining the deposition of the fibrotic matrix for extended periods (Richter and Kietzmann 2016)

Source: Bayer, T

By month 3, early digestive effects may be less intense if treatment is tolerated, but a dose increase can trigger another flare

The results can last from several weeks to a few months, and then it may be time for a follow-up appointment

R., Shepherd, P

Have you had a homocysteine blood test and a methylmalonic acid - MMA - that would show whether you were low at cellular level